Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
- PMID: 27228567
- DOI: 10.1002/hep.28655
Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
Abstract
A population of stromal cells, myeloid-derived suppressor cells (MDSCs), is present in tumors. Though studies have gradually revealed the protumorigenic functions of MDSCs, the molecular mechanisms guiding MDSC recruitment remain largely elusive. Hypoxia, O2 deprivation, is an important factor in the tumor microenvironment of solid cancers, whose growth often exceeds the growth of functional blood vessels. Here, using hepatocellular carcinoma as the cancer model, we show that hypoxia is an important driver of MDSC recruitment. We observed that MDSCs preferentially infiltrate into hypoxic regions in human hepatocellular carcinoma tissues and that hypoxia-induced MDSC infiltration is dependent on hypoxia-inducible factors. We further found that hypoxia-inducible factors activate the transcription of chemokine (C-C motif) ligand 26 in cancer cells to recruit chemokine (C-X3-C motif) receptor 1-expressing MDSCs to the primary tumor. Knockdown of chemokine (C-C motif) ligand 26 in cancer cells profoundly reduces MDSC recruitment, angiogenesis, and tumor growth. Therapeutically, blockade of chemokine (C-C motif) ligand 26 production in cancer cells by the hypoxia-inducible factor inhibitor digoxin or blockade of chemokine (C-X3-C motif) receptor 1 in MDSCs by chemokine (C-X3-C motif) receptor 1 neutralizing antibody could substantially suppress MDSC recruitment and tumor growth.
Conclusion: This study unprecedentedly reveals a novel molecular mechanism by which cancer cells direct MDSC homing to primary tumor and suggests that targeting MDSC recruitment represents an attractive therapeutic approach against solid cancers. (Hepatology 2016;64:797-813).
© 2016 by the American Association for the Study of Liver Diseases.
Similar articles
-
CCL9/CCR1 induces myeloid‑derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model.Oncol Rep. 2019 Jan;41(1):608-618. doi: 10.3892/or.2018.6809. Epub 2018 Oct 18. Oncol Rep. 2019. PMID: 30365155
-
Receptor-Interacting Protein Kinase 3 Deficiency Recruits Myeloid-Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C-X-C Motif) Ligand 1-Chemokine (C-X-C Motif) Receptor 2 Axis.Hepatology. 2019 Nov;70(5):1564-1581. doi: 10.1002/hep.30676. Epub 2019 Jul 17. Hepatology. 2019. PMID: 31021443 Free PMC article.
-
Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially.Int Immunopharmacol. 2015 Jun;26(2):314-21. doi: 10.1016/j.intimp.2015.04.010. Epub 2015 Apr 16. Int Immunopharmacol. 2015. PMID: 25891236
-
Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy.Oncoimmunology. 2015 Feb 3;4(1):e954829. doi: 10.4161/21624011.2014.954829. eCollection 2015 Jan. Oncoimmunology. 2015. PMID: 25949858 Free PMC article. Review.
-
Phytochemicals inhibit the immunosuppressive functions of myeloid-derived suppressor cells (MDSC): Impact on cancer and age-related chronic inflammatory disorders.Int Immunopharmacol. 2018 Aug;61:231-240. doi: 10.1016/j.intimp.2018.06.005. Epub 2018 Jun 9. Int Immunopharmacol. 2018. PMID: 29894862 Review.
Cited by
-
Tumor-related stress regulates functional plasticity of MDSCs.Cell Immunol. 2021 May;363:104312. doi: 10.1016/j.cellimm.2021.104312. Epub 2021 Feb 12. Cell Immunol. 2021. PMID: 33652258 Free PMC article. Review.
-
Nanoparticle-Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy.Adv Mater. 2023 May;35(21):e2206370. doi: 10.1002/adma.202206370. Epub 2023 Apr 2. Adv Mater. 2023. PMID: 36524978 Free PMC article. Review.
-
Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development.Cancers (Basel). 2019 Dec 11;11(12):1989. doi: 10.3390/cancers11121989. Cancers (Basel). 2019. PMID: 31835751 Free PMC article. Review.
-
CX3CR1+ Macrophage Facilitates the Resolution of Allergic Lung Inflammation via Interacting CCL26.Am J Respir Crit Care Med. 2023 Jun 1;207(11):1451-1463. doi: 10.1164/rccm.202209-1670OC. Am J Respir Crit Care Med. 2023. PMID: 36790376 Free PMC article.
-
Hypoxia-Driven Immune Escape in the Tumor Microenvironment.Cells. 2020 Apr 16;9(4):992. doi: 10.3390/cells9040992. Cells. 2020. PMID: 32316260 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous